rs60593994

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_021098.3(CACNA1H):​c.489G>C​(p.Gln163His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00402 in 1,602,790 control chromosomes in the GnomAD database, including 57 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Q163P) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0036 ( 5 hom., cov: 33)
Exomes 𝑓: 0.0041 ( 52 hom. )

Consequence

CACNA1H
NM_021098.3 missense

Scores

9
9

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 1.63

Publications

8 publications found
Variant links:
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
  • hyperaldosteronism, familial, type IV
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • childhood absence epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • epilepsy, childhood absence, susceptibility to, 6
    Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.009828389).
BP6
Variant 16-1195509-G-C is Benign according to our data. Variant chr16-1195509-G-C is described in ClinVar as Benign. ClinVar VariationId is 460131.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00363 (552/152246) while in subpopulation SAS AF = 0.0162 (78/4826). AF 95% confidence interval is 0.0133. There are 5 homozygotes in GnomAd4. There are 302 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 552 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1HNM_021098.3 linkc.489G>C p.Gln163His missense_variant Exon 4 of 35 ENST00000348261.11 NP_066921.2 O95180-1B3KQH9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1HENST00000348261.11 linkc.489G>C p.Gln163His missense_variant Exon 4 of 35 1 NM_021098.3 ENSP00000334198.7 O95180-1
CACNA1HENST00000569107.6 linkc.489G>C p.Gln163His missense_variant Exon 4 of 34 1 ENSP00000454990.2 H3BNT0
CACNA1HENST00000711493.1 linkc.489G>C p.Gln163His missense_variant Exon 4 of 34 ENSP00000518778.1
CACNA1HENST00000565831.7 linkc.489G>C p.Gln163His missense_variant Exon 4 of 34 1 ENSP00000455840.1 O95180-2
CACNA1HENST00000711450.1 linkc.489G>C p.Gln163His missense_variant Exon 4 of 35 ENSP00000518762.1
CACNA1HENST00000564231.6 linkc.489G>C p.Gln163His missense_variant Exon 4 of 35 1 ENSP00000457555.2 H3BUA8
CACNA1HENST00000638323.1 linkc.450G>C p.Gln150His missense_variant Exon 4 of 35 5 ENSP00000492267.1 A0A1W2PR14
CACNA1HENST00000562079.6 linkc.489G>C p.Gln163His missense_variant Exon 4 of 34 1 ENSP00000454581.2 H3BMW6
CACNA1HENST00000711438.1 linkc.450G>C p.Gln150His missense_variant Exon 4 of 34 ENSP00000518754.1
CACNA1HENST00000711482.1 linkc.489G>C p.Gln163His missense_variant Exon 4 of 36 ENSP00000518771.1
CACNA1HENST00000711485.1 linkc.489G>C p.Gln163His missense_variant Exon 4 of 35 ENSP00000518774.1
CACNA1HENST00000711455.1 linkc.489G>C p.Gln163His missense_variant Exon 4 of 36 ENSP00000518768.1
CACNA1HENST00000711483.1 linkc.489G>C p.Gln163His missense_variant Exon 4 of 35 ENSP00000518772.1
CACNA1HENST00000711456.1 linkc.489G>C p.Gln163His missense_variant Exon 4 of 34 ENSP00000518769.1
CACNA1HENST00000621827.2 linkn.489G>C non_coding_transcript_exon_variant Exon 4 of 37 6 ENSP00000518766.1
CACNA1HENST00000637236.3 linkn.489G>C non_coding_transcript_exon_variant Exon 4 of 34 5 ENSP00000492650.2 A0A1W2PS38
CACNA1HENST00000639478.1 linkn.489G>C non_coding_transcript_exon_variant Exon 4 of 35 5 ENSP00000491945.1 A0A1W2PQW2
CACNA1HENST00000640028.1 linkn.489G>C non_coding_transcript_exon_variant Exon 4 of 35 5 ENSP00000491488.1 A0A1W2PQ19
CACNA1HENST00000711442.1 linkn.489G>C non_coding_transcript_exon_variant Exon 4 of 34 ENSP00000518758.1
CACNA1HENST00000711448.1 linkn.489G>C non_coding_transcript_exon_variant Exon 4 of 36 ENSP00000518760.1
CACNA1HENST00000711449.1 linkn.489G>C non_coding_transcript_exon_variant Exon 4 of 35 ENSP00000518761.1
CACNA1HENST00000711451.1 linkn.489G>C non_coding_transcript_exon_variant Exon 4 of 36 ENSP00000518763.1
CACNA1HENST00000711452.1 linkn.489G>C non_coding_transcript_exon_variant Exon 4 of 36 ENSP00000518764.1
CACNA1HENST00000711453.1 linkn.489G>C non_coding_transcript_exon_variant Exon 4 of 36 ENSP00000518765.1
CACNA1HENST00000711484.1 linkn.489G>C non_coding_transcript_exon_variant Exon 4 of 35 ENSP00000518773.1
CACNA1HENST00000711486.1 linkn.489G>C non_coding_transcript_exon_variant Exon 4 of 37 ENSP00000518775.1
CACNA1HENST00000711487.1 linkn.489G>C non_coding_transcript_exon_variant Exon 4 of 36 ENSP00000518776.1
CACNA1HENST00000711488.1 linkn.489G>C non_coding_transcript_exon_variant Exon 4 of 35 ENSP00000518777.1

Frequencies

GnomAD3 genomes
AF:
0.00364
AC:
553
AN:
152128
Hom.:
5
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000579
Gnomad AMI
AF:
0.00219
Gnomad AMR
AF:
0.00294
Gnomad ASJ
AF:
0.00490
Gnomad EAS
AF:
0.000578
Gnomad SAS
AF:
0.0161
Gnomad FIN
AF:
0.00763
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.00426
Gnomad OTH
AF:
0.00478
GnomAD2 exomes
AF:
0.00490
AC:
1126
AN:
229966
AF XY:
0.00593
show subpopulations
Gnomad AFR exome
AF:
0.000583
Gnomad AMR exome
AF:
0.00221
Gnomad ASJ exome
AF:
0.00446
Gnomad EAS exome
AF:
0.0000595
Gnomad FIN exome
AF:
0.00547
Gnomad NFE exome
AF:
0.00378
Gnomad OTH exome
AF:
0.00610
GnomAD4 exome
AF:
0.00406
AC:
5888
AN:
1450544
Hom.:
52
Cov.:
34
AF XY:
0.00453
AC XY:
3266
AN XY:
720216
show subpopulations
African (AFR)
AF:
0.000781
AC:
26
AN:
33312
American (AMR)
AF:
0.00241
AC:
104
AN:
43160
Ashkenazi Jewish (ASJ)
AF:
0.00459
AC:
119
AN:
25910
East Asian (EAS)
AF:
0.0000510
AC:
2
AN:
39228
South Asian (SAS)
AF:
0.0170
AC:
1428
AN:
83762
European-Finnish (FIN)
AF:
0.00523
AC:
275
AN:
52534
Middle Eastern (MID)
AF:
0.0208
AC:
119
AN:
5710
European-Non Finnish (NFE)
AF:
0.00319
AC:
3529
AN:
1106930
Other (OTH)
AF:
0.00477
AC:
286
AN:
59998
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.464
Heterozygous variant carriers
0
331
663
994
1326
1657
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
122
244
366
488
610
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00363
AC:
552
AN:
152246
Hom.:
5
Cov.:
33
AF XY:
0.00406
AC XY:
302
AN XY:
74450
show subpopulations
African (AFR)
AF:
0.000578
AC:
24
AN:
41548
American (AMR)
AF:
0.00294
AC:
45
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00490
AC:
17
AN:
3470
East Asian (EAS)
AF:
0.000580
AC:
3
AN:
5176
South Asian (SAS)
AF:
0.0162
AC:
78
AN:
4826
European-Finnish (FIN)
AF:
0.00763
AC:
81
AN:
10618
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.00427
AC:
290
AN:
67988
Other (OTH)
AF:
0.00426
AC:
9
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
27
54
82
109
136
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00471
Hom.:
3
Bravo
AF:
0.00264
ESP6500AA
AF:
0.000492
AC:
2
ESP6500EA
AF:
0.00228
AC:
19
ExAC
AF:
0.00472
AC:
569
Asia WGS
AF:
0.00375
AC:
13
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Jul 17, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 30686625, 32227660) -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nov 05, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Epilepsy, childhood absence, susceptibility to, 6 Benign:1
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Jan 20, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.28
BayesDel_addAF
Benign
-0.15
T
BayesDel_noAF
Uncertain
0.020
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.58
D;.;.;.
Eigen
Benign
-0.093
Eigen_PC
Benign
-0.034
FATHMM_MKL
Uncertain
0.76
D
LIST_S2
Uncertain
0.87
D;D;D;.
MetaRNN
Benign
0.0098
T;T;T;T
MetaSVM
Uncertain
0.50
D
MutationAssessor
Benign
0.76
N;.;N;N
PhyloP100
1.6
PrimateAI
Uncertain
0.54
T
PROVEAN
Benign
-2.3
N;.;N;N
REVEL
Uncertain
0.59
Sift
Benign
0.061
T;.;T;T
Sift4G
Uncertain
0.028
D;.;D;D
Polyphen
0.051
B;.;D;D
Vest4
0.49
MutPred
0.49
Loss of helix (P = 0.028);.;Loss of helix (P = 0.028);Loss of helix (P = 0.028);
MVP
0.91
ClinPred
0.012
T
GERP RS
2.7
Varity_R
0.33
gMVP
0.61
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs60593994; hg19: chr16-1245509; COSMIC: COSV61989280; API